You have 9 free searches left this month | for more free features.

Condition

Bacteremia Caused by Gram-Negative Bacteria (1)

Pseudomonas Aeruginosa (1)

Pseudomonas Infections (1)

Overall Status

Unknown status (1)

Withdrawn (1)

Sign in for free

Phase

phase 3 (1)

Sponsor

Temple University (1)

The University of Queensland (1)

Collaborator

Merck Sharp & Dohme LLC (1)

Intervention

ceftolozane-tazobactam (2)

meropenem (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (1)

Observational (1)

ceftolozane-tazobactam

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Bacteremia Caused by Gram-Negative Bacteria Trial in Worldwide (Ceftolozane-Tazobactam, Meropenem)

Withdrawn

Bacteremia Caused by Gram-Negative Bacteria

Ceftolozane-Tazobactam
Meropenem

Newcastle, New South Wales, Australia
+28 more

May 17, 2022

Ceftolozane-tazobactam for MDR Pseudomonas Infections

Unknown status

Pseudomonas Infections
Pseudomonas Aeruginosa

Ceftolozane-Tazobactam

Philadelphia, Pennsylvania

Temple University, School of Pharmacy

Apr 17, 2018